InsidersTradesSigma
Corbus Pharmaceuticals Holdings, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Corbus Pharmaceuticals Holdings, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Corbus Pharmaceuticals Holdings, Inc. has logged 47 public disclosures. Market capitalisation: €1.9bn. The latest transaction was filed on 11 June 2026 (Cession). Among the most active insiders: Moran Sean F.. The full history is accessible without an account.
47
Insider Decl.
0
Thresholds
€16m
12 ops.
Buy Volume
€141,876
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Corbus Pharmaceuticals Holdings, Inc. Strong Buy (bullish), based on 11 analysts. Average price target: US$56.64.
48Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2026
Declarations47 total
2,412 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267655:0
4,800 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267671:0
2,026 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267672:0
58,300 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-237103:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234851:0
7,500 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234813:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234853:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234857:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234860:0
1,060 shares@ US$4.8019.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-25-245262:0
1,060 shares@ US$20.5081.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-25-245262:1
6,393 shares@ US$6.7777100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-25-035547:0
2,792 shares@ US$8.755917.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-25-022514:0
7,134 shares@ US$8.755918.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-25-022512:0
27,500 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-25-013702:0
68,100 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-25-013697:0
27,200 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-25-013704:0
45,085 shares@ US$17.4754.5% of flowCommon StockSEC:0000929638-24-003217:0
Ideal exit: 17 Jun 2025 (T+270)
5,566 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-24-099175:0
16,830 shares@ US$14.1069.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-24-075071:0
1,567 shares@ US$30.0033.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-24-075075:0
1,667 shares@ US$30.0094.2% of flowCommon Stock, par value $0.0001 per shareSEC:0000950170-24-073710:0
2,783 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-24-068014:0
2,783 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-24-068030:0
25 of 47 declarations
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing treatments for inflammatory and fibrotic diseases. It is listed on NASDAQ under the ticker CRBP.